BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
PSNY
Polestar Automotive Holding UK PLC
There isn't enough reported data to score PSNY yet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
PSNY Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Stable |
PSNY's balance sheet is currently stable, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | โ |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
PSNY PE Valuation
PSNY has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over PSNY on the outlook, with more favorable earnings and revenue expectations.
PSNY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect PSNY's losses to grow, with revenue declining.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
PSNY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2023 | -$16.80 | -$9.90 |
PSNY and BABA do not have enough comparable growth data to identify a winner.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
PSNY has the stronger quarterly revenue trend. Revenue is up 8.3% for BABA versus up 16% for PSNY.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
PSNY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $1.4B | +57% |
| Q4 2024 | $1.1B | -0.2% |
| Q2 2024 | $905.8M | -26% |
| Q4 2023 | $1.1B | -54% |
| Q4 2022 | $2.5B | +318% |
| Q4 2021 | $589.5M | +100% |
| Q3 2021 | $212.9M | -28% |
| Q2 2021 | $267.4M | +2573% |
PSNY's revenue is recovering but still below its 2022 peak: $1.4B last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -77% | -52 points |
| Q4 2024 | -120% | -101 points |
| Q2 2024 | -51% | +5.9 points |
| Q4 2023 | -86% | +52 points |
| Q2 2023 | -25% | -25 points |
| Q4 2022 | -18% | -18 points |
| Q4 2021 | -57% | -57 points |
| Q3 2021 | -138% | -98 points |
PSNY's operating margin was โ77% last quarter, down 52 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
PSNY has the stronger cash trend. Its trailing FCF is down 120% versus its history, compared with BABA at down 158%.
PSNY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | -$585.7M | -$332.1M |
| Q4 2024 | -$885.6M | +$442.5M |
| Q2 2024 | -$253.5M | +$450.1M |
| Q4 2023 | -$1.3B | -$212.4M |
| Q4 2022 | -$1.1B | -$901.1M |
| Q4 2021 | -$214.6M | -1961% |
| Q3 2021 | -$55.5M | -581% |
| Q2 2021 | -$8.3M | +$56.5M |
PSNY has burned cash in almost every quarter: โ$3.1B over the past year, against โ$2.1B the year before.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
PSNY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | 2.6x | Moderate |
PSNY's net debt is about 2.6 years of its operating earnings (EBITDA).
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
PSNY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.9 | Oversold |
| Stochastic | 8.4 | Oversold |
PSNY's weekly RSI is 27 (oversold) and its Stochastic is 8 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
PSNY PE vs Consumer Cyclical Sector
PSNY has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
PSNY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.83 | 12% below |
| 20 week MA | $10.0 | 57% below |
| 50 week MA | $15.2 | 72% below |
| 100 week MA | $22.9 | 81% below |
| 200 week MA | $47.9 | 91% below |
PSNY is in a downtrend: it's below all five of its weekly moving averages, and 91% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over PSNY on returns for 2026, with the stronger performance.
PSNY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $292.8 | $346.5 | +18% |
| 2022 | $346.5 | $146.4 | -58% |
| 2023 | $146.4 | $67.8 | -54% |
| 2024 | $67.8 | $33.3 | -51% |
| 2025 | $33.3 | $17.5 | -47% |
| 2026 YTD | $17.5 | $4.26 | -76% |
PSNY has finished four years in a row lower, and it's down 76% so far in 2026.